World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
62182
World Ranking
6656
National Ranking
255

Laurence Collette publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Laurence Collette sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 393 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Laurence Collette D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Laurence Collette sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 105 D-Index — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Laurence Collette is affiliated with the European Organisation for Research and Treatment of Cancer in the Netherlands. Their primary research field falls within Medicine, with a particular focus on several subfields including Pulmonary and Respiratory Medicine, Surgery, Oncology, Statistics and Probability, and Radiology, Nuclear Medicine and Imaging.

Their scholarly work covers a range of topics, notably Prostate Cancer Treatment and Research, Testicular Diseases and Treatments, Prostate Cancer Diagnosis and Treatment, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life issues, Global Cancer Incidence and Screening, and Radiomics and Machine Learning in Medical Imaging.

Laurence Collette has authored multiple papers, with notable publications including:

  • "Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation," 2020, The Lancet Oncology
  • "Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group," 2021, Radiotherapy and Oncology
  • "International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium," 2020, The Lancet Oncology
  • "Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium," 2021, Journal of Clinical Oncology
  • "Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium," 2021, Journal of Clinical Oncology

Frequent co-authors collaborating with Laurence Collette include:

  • Silke Gillessen
  • Bertrand Tombal
  • Robert Huddart
  • Christopher J. Sweeney
  • J. Beyer

The scientist's publications frequently appear in several academic venues, with a record of multiple publications in the following journals:

  • Journal of Clinical Oncology
  • Radiotherapy and Oncology
  • European Urology Open Science
  • The Lancet Oncology
  • European Urology

Laurence Collette's research integrates clinical trial methodology, cancer treatment outcomes, and the development of consensus recommendations, reflecting involvement in interdisciplinary medical research across oncology and associated domains.

Best Publications

  • Chemotherapy with preoperative radiotherapy in rectal cancer

    Jean-François Bosset;Laurence Collette;Gilles Calais;Laurent Mineur

  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Bengt Glimelius;Graeme J Poston

  • Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

    Michel Bolla;Laurence Collette;Léo Blank;Padraig Warde

  • Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study

    Martin Kocher;Riccardo Soffietti;Ufuk M. Abacioglu;Salvador Villa

  • Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial

    Jean-Louis Lefebvre;Dominique Chevalier;Bernard Luboinski;Anne Kirkpatrick

  • Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

    Michel Bolla;Dionisio Gonzalez;Padraig Warde;Jean Bernard Dubois

  • Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

    Michel Bolla;Hendrik Van Poppel;Laurence Collette;Paul van Cangh

  • Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial

    Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans

  • Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer

    Berend J Slotman;Corinne Faivre-Finn;Gijs Kramer;Elaine M Rankin

  • Duration of androgen suppression in the treatment of prostate cancer.

    Michel Bolla;Theodorus M. de Reijke;Geertjan Van Tienhoven;Alphonsus C.M. Van den Bergh

  • Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.

    MJ van den Bent;D Afra;O de Witte;M Ben Hassel

  • Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.

    Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans

  • External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

    Michel Bolla;Geertjan Van Tienhoven;Padraig Warde;Jean Bernard Dubois

  • Internal mammary and medial supraclavicular irradiation in breast cancer

    P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen

  • Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

    Michel Bolla;Hein van Poppel;Bertrand Tombal;Kris Vekemans

  • Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

    C. Viscoli;C. Girmenia;A. Marinus;L. Collette

  • Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.

    Matthias Guckenberger;Yolande Lievens;Angelique B Bouma;Laurence Collette

  • Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

    Maurizio Brausi;Laurence Collette;Karlheinz Kurth;Adrian P. van der Meijden

  • Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

    Cora N. Sternberg;P. H.M. De Mulder;J. H. Schornagel;C. Théodore

  • Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results—EORTC 22921

    Jean-François Bosset;Gilles Calais;Laurent Mineur;Philippe Maingon

Frequent Co-Authors

Harry Bartelink
Harry Bartelink Antoni van Leeuwenhoek Hospital
Richard Sylvester
Richard Sylvester European Organisation for Research and Treatment of Cancer
Philip Poortmans
Philip Poortmans University of Antwerp
Alain Fourquet
Alain Fourquet Institute Curie
Urs E. Studer
Urs E. Studer University of Bern
Cora N. Sternberg
Cora N. Sternberg Cornell University
Bertrand Tombal
Bertrand Tombal Université Catholique de Louvain
Andrew Bottomley
Andrew Bottomley European Organisation for Research and Treatment of Cancer

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn’t always mean following the traditional route to become a physician. There are several rewarding healthcare pathways that can be pursued online and with more accessible admissions requirements.

For those interested in nursing, there are easiest nursing schools to get into, making this a practical and achievable entry point to patient care roles. Many schools now offer programs tailored to diverse student backgrounds, including absn programs that don't require teas or HESI exam scores, lowering barriers for applicants.

Prefer a non-clinical path? There are healthcare careers you can pursue without direct patient contact, such as medical coding. Accredited medical coding and billing classes online with financial aid are widely available and often allow you to earn certifications that are in demand across hospitals and clinics.

Leadership and management opportunities also abound. Accredited online health administration programs can prepare you for fast-paced administrative and executive roles—even while working.

Exploring these alternative online healthcare degrees can lead to stable, well-paying, and meaningful careers in the growing field of medicine.

Best Scientists Citing Laurence Collette

Trending Scientists

Recently Published Articles